J1448 Injection, trilaciclib, 1mg
J-Codes
Also known as: trilaciclib, CDK4/6 inhibitor
Trilaciclib injection, 1 milligram. A cyclin-dependent kinase inhibitor for chemotherapy-induced myelosuppression management.
Clinical Context
Used prior to chemotherapy administration to reduce chemotherapy-induced myelosuppression in cancer patients. Given intravenously before chemotherapy sessions.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.